Episodic or chronic? Distinguishing between the 2 types of migraine is essential to ensure optimal treatment. Meet Abigail and Martin. Who has which headache?
FDA Grants First-in-Class Marketing Authorization for Digital Therapeutic in Episodic Migraine Prevention
CT-132 is a 12-week app-based intervention that uses validated behavioral techniques to modulate labile brain circuitry involved in migraine, according to Click Therapeutics.
Distress Signals: How to Help a Clinician Colleague in Need
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Rebekah Bernard, MD, a family physician and national speaker on physician wellness.
Gantenerumab May Delay Alzheimer Disease Symptoms in High-Risk Adults: Daily Dose
Your daily dose of the clinical news you may have missed.
Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Lynn Webster, MD, past president of the American Academy of Pain Medicine.
Trontinemab: Roche Announces Phase 3 Development Program for the mAb in Adults with Early Alzheimer Disease
Using the proprietary Roche Brainshuttle technology, trontinemab leads to deep, rapid amyloid plaque reduction with a favorable safety profile.
For Sleep Disturbance in Alzheimer Disease, Cannabinoid-Based IGC-AD1 Shines in Phase 2